This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2011-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2012
Title: Frank DeRosa: Innovator in Nitric Oxide-Releasing Polymers
Introduction
Frank DeRosa is a notable inventor based in Nanuet, NY (US), recognized for his contributions to the field of medical devices through his innovative work on nitric oxide-releasing polymers. With a total of two patents to his name, DeRosa's inventions have significant implications for therapeutic applications.
Latest Patents
DeRosa's latest patents focus on nitric oxide-releasing diazeniumdiolated compounds. The first patent describes novel nitric oxide-releasing polymers that consist of at least two adjacent units derived from acrylonitrile monomer units, containing at least one carbon-bound diazeniumdiolate. These polymers are designed for use in medical devices therapeutically. The invention also outlines methods for treating biological disorders and promoting angiogenesis by administering a medical device that incorporates these nitric oxide-releasing polymers. The second patent reiterates similar concepts, emphasizing the therapeutic potential of diazeniumdiolated acrylonitrile-derived polymers in medical applications.
Career Highlights
Frank DeRosa is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution has allowed him to contribute significantly to advancements in medical technology and therapeutic methods.
Collaborations
DeRosa has collaborated with esteemed colleagues such as Joseph A. Hrabie and Larry K. Keefer, enhancing the research and development of his innovative projects.
Conclusion
Frank DeRosa's work in developing nitric oxide-releasing polymers showcases his commitment to advancing medical technology. His patents reflect a significant contribution to therapeutic methods that can improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile